Literature DB >> 11180407

Wild-type p53 inhibits protein kinase CK2 activity.

N Schuster1, C Götz, M Faust, E Schneider, A Prowald, A Jungbluth, M Montenarh.   

Abstract

The growth suppressor protein p53 and the protein kinase CK2 are both implicated in cellular growth regulation. We previously found that p53 binds to protein kinase CK2 via its regulatory beta-subunit. In the present study, we analyzed the consequences of the binding of p53 to CK2 for the enzymatic activity of CK2 in vitro and in vivo. We found that the carboxy-terminus of p53 which is a potent transforming agent stimulated CK2 activity whereas full length wild-type p53 which is a growth suppressor inhibited the activity of protein kinase CK2. Inhibition of protein kinase CK2 by p53 was dose-dependent and was seen for various CK2 substrates. Experiments with heat-denatured p53 and the conformational mutant p53(R175H) revealed that an intact conformation of p53 seemed to be necessary. Transfection of wild-type and of mutant p53 into p53-/- cells showed that the inhibition of p53 on CK2 activity was also detectable in intact cells and specific for wild-type p53 indicating that the growth suppressing function of p53 might at least be partially achieved by down-regulation of protein kinase CK2. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180407     DOI: 10.1002/1097-4644(20010401)81:1<172::aid-jcb1033>3.0.co;2-o

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

1.  Localization of individual subunits of protein kinase CK2 to the endoplasmic reticulum and to the Golgi apparatus.

Authors:  M Faust; M Jung; J Günther; R Zimmermann; M Montenarh
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

Review 2.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

3.  Modulation of mammalian life span by the short isoform of p53.

Authors:  Bernhard Maier; Wendy Gluba; Brian Bernier; Terry Turner; Khalid Mohammad; Theresa Guise; Ann Sutherland; Michael Thorner; Heidi Scrable
Journal:  Genes Dev       Date:  2004-02-01       Impact factor: 11.361

4.  Peptides from phage display library modulate gene expression in mesenchymal cells and potentiate osteogenesis in unicortical bone defects.

Authors:  Gary Balian; Gina Beck; Vedavathi Madhu; Robert Sikes; Quanjun Cui; Haixiang Liang; Joshua Bush
Journal:  J Vis Exp       Date:  2010-12-10       Impact factor: 1.355

Review 5.  Ecto-protein kinase CK2, the neglected form of CK2.

Authors:  Mathias Montenarh; Claudia Götz
Journal:  Biomed Rep       Date:  2018-02-21

6.  Regulation of Ikaros function by casein kinase 2 and protein phosphatase 1.

Authors:  Chunhua Song; Zhanjun Li; Amy K Erbe; Aleksandar Savic; Sinisa Dovat
Journal:  World J Biol Chem       Date:  2011-06-26

Review 7.  Induction and activation of the p53 pathway: a role for the protein kinase CK2?

Authors:  David W Meek; Miranda Cox
Journal:  Mol Cell Biochem       Date:  2011-07-19       Impact factor: 3.396

8.  Immunologically defined subclasses of the protein kinase CK2 beta-subunit in prostate carcinoma cell lines.

Authors:  Claudia Götz; Sabine Kartarius; Sarah Schetting; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

9.  CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor.

Authors:  P P Scaglioni; T M Yung; S Choi; S C Choi; C Baldini; G Konstantinidou; P P Pandolfi
Journal:  Mol Cell Biochem       Date:  2008-06-20       Impact factor: 3.396

Review 10.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.